입도 분석 시장 : 제품별, 분산 방식별, 최종사용자별 - 세계 예측(-2031년)

The global particle size analysis market is projected to reach USD 7.73 billion by 2031 from USD 5.12 billion in 2025, at a CAGR of 6.5% from 2026 to 2031. Growing demand for pharmaceuticals, biologics, and nanotechnology is increasing the need for precise particle-size characterization to maintain product quality and performance.

At the same time, the market is moving toward advanced, automated, and AI-driven analytical systems that enable faster, high-throughput, and more accurate measurements.

"The laser diffraction segment held the largest share of the market in 2025."

Based on the technology, the particle size analysis market is segmented into laser diffraction, dynamic light scattering, imaging, Coulter principle, nanoparticle tracking analysis, sieve analysis, and other technologies. In 2025, the laser diffraction segment holds the largest share in the particle size analysis market. The laser diffraction segment is experiencing strong growth in the particle size analysis market due to its high accuracy, speed, and versatility across a wide particle size range, making it suitable for both wet and dry sample analysis across industries such as pharmaceuticals, chemicals, food, and mining. A key trend driving its adoption is the increasing demand for precise quality control and regulatory compliance, especially in biopharma and advanced materials, where consistent particle size is critical for product performance.

"The wet dispersion segment held the largest share of the market in 2025."

Based on dispersion, the particle size analysis market is segmented into wet, dry, and spray dispersion. In 2025, the wet dispersion segment holds the largest share in the particle size analysis market. The wet dispersion segment is growing strongly in the particle size analysis market due to its ability to deliver highly accurate, reproducible, and reliable measurements for fine particles, suspensions, and emulsions, which are increasingly used in pharmaceuticals, nanotechnology, and advanced materials. A key trend driving this growth is the rising demand for liquid-based formulations such as biologics, drug suspensions, and chemical slurries, in which wet dispersion provides better particle separation and minimizes agglomeration, thereby improving data precision.

"The healthcare industry segment held the largest share of the market in 2025."

Based on end user, the particle size analysis market is segmented into the healthcare industry (pharmaceutical and biotechnology companies, public and private research institutions, academic institutions), cosmetic industry, chemical and petroleum industry, mining, minerals, and cement industry, food and beverages industry, and other industries. In 2025, the healthcare industry segment holds the largest share in the particle size analysis market. The healthcare end-user segment is witnessing strong growth in the particle size analysis market due to the increasing demand for advanced drug development, biologics, and nanoparticle-based therapies, where precise particle characterization is critical for safety and efficacy. The rising focus on drug delivery systems, vaccines, diagnostic assays, and medical devices is further driving adoption, as particle size directly impacts bioavailability, stability, and performance. Additionally, growing investments in pharmaceutical R&D, expanding healthcare infrastructure, and strict regulatory requirements are pushing the need for accurate and reliable particle analysis solutions, making healthcare one of the fastest-growing segments in the market.

"The market in the Asia Pacific region is expected to witness the highest growth during the forecast period."

Asia-Pacific is emerging as the fastest-growing region in the particle size analysis market, driven by rapid industrialization, expanding pharmaceutical and chemical manufacturing, and increasing investments in nanotechnology and R&D across countries like China, India, Japan, and South Korea. The region benefits from strong government support, growing regulatory focus on product quality, and rising adoption of advanced analytical technologies in industries such as healthcare, electronics, and materials science. Additionally, the presence of cost-effective manufacturing, a large skilled workforce, and increasing global company expansion into emerging markets is accelerating demand for particle size analysis instruments, making Asia Pacific the key growth engine for the market.

A breakdown of the primary participants referred to for this report is provided below:

• By Company Type: Tier 1-48%, Tier 2-36%, and Tier 3- 16%
• By Designation: C-level-10%, Director-level-14%, and Others-76%
• By Region: North America-40%, Europe-32%, Asia Pacific-20%, Latin America-5%, and the Middle East & Africa-3%

As of 2025, the leading participants in the global particle size analysis market include Spectris (UK), HORIBA (Japan), Danaher (US), Anton Paar GmbH (Austria), Bettersize Instruments Ltd. (China), Brookhaven Instruments (US), Fritsch GmbH (Germany), LS Instruments (Switzerland), Metller Toledo (US), Micromeritics Instrument Corporation (US), Microtrac Retsch GmbH (Germany), Shimadzu Corporation (Japan), Sympatec GmbH (Germany), and TSI (US), among others. These companies employ a range of strategic initiatives such as mergers and acquisitions, collaborations, partnerships, and product launches to strengthen their presence and expand their share in the global market.

Research Coverage

This report studies the particle size analysis market based on technology, dispersion, type, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micromarkets by growth trends and forecasts revenue for the market segments across five main regions (and the respective countries within these regions).

Reasons to Buy the Report

The report will help market leaders/new entrants with information on the closest approximations of revenue for the overall particle size analysis market and its subsegments. This report will help stakeholders understand the competitive landscape and gain additional insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:

• Analysis of key drivers (Growing demand for precision in pharmaceuticals & biologics), restraints (High cost of advanced instruments), opportunities (inline & real-time monitoring in manufacturing), and challenges (skill gap in advanced analytics) influencing the growth of the life science instrumentation market
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the particle size analysis market
• Market Development: Comprehensive information about lucrative markets-the report analyzes the particle size analysis market across varied regions
• Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the particle size analysis market
• Competitive Assessment: In-depth assessment of market share, growth strategies, and service offerings of leading players like Spectris (UK), HORIBA (Japan), Danaher (US), Anton Paar GmbH (Austria), Bettersize Instruments Ltd. (China), Brookhaven Instruments (US), Fritsch GmbH (Germany), LS Instruments (Switzerland), and others.

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKET SEGMENTATION
  • 1.3.2 INCLUSIONS & EXCLUSIONS
• 1.4 YEARS CONSIDERED
• 1.5 CURRENCY CONSIDERED
• 1.6 RESEARCH LIMITATIONS
• 1.7 STAKEHOLDERS

2 EXECUTIVE SUMMARY

• 2.1 MARKET HIGHLIGHTS AND KEY INSIGHTS
• 2.2 KEY MARKET PARTICIPANTS: MAPPING OF STRATEGIC DEVELOPMENTS
• 2.3 DISRUPTIVE TRENDS IN PARTICLE SIZE ANALYSIS MARKET
• 2.4 HIGH GROWTH SEGMENTS

3 PREMIUM INSIGHTS

• 3.1 MARKET OVERVIEW
• 3.2 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY
• 3.3 REGIONAL SNAPSHOT OF PARTICLE SIZE ANALYSIS MARKET

4 MARKET OVERVIEW

• 4.1 INTRODUCTION
• 4.2 MARKET DYNAMICS
  • 4.2.1 DRIVERS
    • 4.2.1.1 Rapid Growth of mRNA, Lipid Nanoparticle (LNP), and Biologic Therapeutics Driving Demand for Precise Nanoparticle Characterization
    • 4.2.1.2 AI-Enabled Automation and Intelligent Software Enhancing Operational Efficiency and Expanding Instrument Adoption
    • 4.2.1.3 Increasing investments in pharmaceutical R&D
    • 4.2.1.4 Stringent regulatory guidelines for product quality across industries
  • 4.2.2 RESTRAINTS
    • 4.2.2.1 High cost of particle size analyzers
    • 4.2.2.2 Limitations in particle characterization range
  • 4.2.3 OPPORTUNITIES
    • 4.2.3.1 Increasing number of conferences and events
    • 4.2.3.2 Expanding applications of particle size analysis in quality control and contamination detection across emerging industries
  • 4.2.4 CHALLENGES
    • 4.2.4.1 Lack of well-established distribution network among SMEs
    • 4.2.4.2 Limitations of laser diffraction technology
• 4.3 UNMET NEEDS AND WHITE SPACES
• 4.4 STRATEGIC MOVES BY TIER 1/2/3 PLAYERS

5 TECHNOLOGICAL ADVANCEMENTS, AI-DRIVEN IMPACTS, PATENTS, INNOVATIONS, AND FUTURE APPLICATIONS

• 5.1 KEY TECHNOLOGIES
  • 5.1.1 LASER DIFFRACTION
  • 5.1.2 COULTER PRINCIPLE (ELECTRICAL SENSING ZONE)
• 5.2 COMPLEMENTARY TECHNOLOGIES
  • 5.2.1 DYNAMIC LIGHT SCATTERING (DLS)
  • 5.2.2 NANOPARTICLE TRACKING ANALYSIS (NTA)
• 5.3 PATENT ANALYSIS
• 5.4 FUTURE APPLICATIONS
• 5.5 IMPACT OF AI/GEN AI ON PARTICLE SIZE ANALYSIS MARKET
  • 5.5.1 TOP USE CASES AND MARKET POTENTIAL
  • 5.5.2 BEST PRACTICES FOLLOWED BY COMPANIES IN PARTICLE SIZE ANALYSIS MARKET
  • 5.5.3 CASE STUDIES RELATED TO AI/GEN AI IMPLEMENTATION IN PARTICLE SIZE ANALYSIS MARKET
  • 5.5.4 INTERCONNECTED ECOSYSTEM AND IMPACT ON MARKET PLAYERS
  • 5.5.5 CLIENT'S READINESS TO ADOPT AI/GEN AI IN PARTICLE SIZE ANALYSIS MARKET
• 5.6 SUCCESS STORIES AND REAL-WORLD APPLICATIONS
  • 5.6.1 KEY APPLICATIONS AND INDUSTRIAL OUTCOMES ENABLED BY PARTICLE SIZE ANALYZERS

6 CUSTOMER LANDSCAPE AND BUYER BEHAVIOR

• 6.1 DECISION-MAKING PROCESS
• 6.2 KEY STAKEHOLDERS IN BUYING PROCESS AND EVALUATION CRITERIA
  • 6.2.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 6.2.2 KEY BUYING CRITERIA
• 6.3 ADOPTION BARRIERS AND INTERNAL CHALLENGES
• 6.4 UNMET NEEDS OF VARIOUS APPLICATIONS

7 REGULATORY ANALYSIS

• 7.1 NORTH AMERICA
  • 7.1.1 US
    • 7.1.1.1 Key regulatory bodies and government agencies
• 7.2 INDUSTRY STANDARDS

8 INDUSTRY TRENDS

• 8.1 PORTER'S FIVE FORCES ANALYSIS
  • 8.1.1 THREAT FROM NEW ENTRANTS
  • 8.1.2 THREAT FROM SUBSTITUTES
  • 8.1.3 BARGAINING POWER OF SUPPLIERS
  • 8.1.4 BARGAINING POWER OF BUYERS
  • 8.1.5 INTENSITY OF COMPETITIVE RIVALRY
• 8.2 MACROECONOMIC OUTLOOK
  • 8.2.1 INTRODUCTION
  • 8.2.2 MACROECONOMIC INDICATORS
    • 8.2.2.1 GDP trends and forecast
    • 8.2.2.2 Trends in global particle size analysis market
• 8.3 VALUE CHAIN ANALYSIS
  • 8.3.1 RAW MATERIAL SUPPLIERS
  • 8.3.2 MANUFACTURERS
  • 8.3.3 SALES & DISTRIBUTION
  • 8.3.4 END USERS
• 8.4 ECOSYSTEM ANALYSIS
• 8.5 PRICING ANALYSIS
  • 8.5.1 AVERAGE SELLING PRICE TREND, BY REGION
  • 8.5.2 AVERAGE SELLING PRICE OF PARTICLE SIZE ANALYZERS, BY KEY PLAYER
• 8.6 TRADE DATA ANALYSIS
  • 8.6.1 IMPORT DATA (HS CODE 903180)
  • 8.6.2 EXPORT DATA (HS CODE 903180)
• 8.7 KEY CONFERENCES & EVENTS, 2026-2027
• 8.8 TRENDS/DISRUPTIONS IMPACTING CUSTOMER BUSINESS
• 8.9 INVESTMENT & FUNDING SCENARIO
• 8.10 CASE STUDY ANALYSIS
  • 8.10.1 CASE STUDY 1: ZETASIZER ULTRA VALIDATION FOR NANOPARTICLE CHARACTERIZATION
  • 8.10.2 CASE STUDY 2: ZETPARTICLE CHARACTERIZATION FOR PHARMACEUTICAL APPLICATIONS
  • 8.10.3 CASE STUDY 3: REAL-TIME VIABLE MONITORING IN PHARMACEUTICAL ASEPTIC MANUFACTURING
• 8.11 PARTICLE SIZE ANALYSIS MARKET - IMPACT OF US TARIFFS
  • 8.11.1 INTRODUCTION
  • 8.11.2 KEY TARIFF RATES
  • 8.11.3 PRICE IMPACT ANALYSIS
  • 8.11.4 IMPACT ON COUNTRY/REGION
    • 8.11.4.1 US
    • 8.11.4.2 Europe
    • 8.11.4.3 Asia Pacific
  • 8.11.5 IMPACT ON END USER

9 PARTICLE SIZE ANALYSIS MARKET, BY TECHNOLOGY

• 9.1 INTRODUCTION
• 9.2 LASER DIFFRACTION
  • 9.2.1 ADVANCED PARTICLE CHARACTERIZATION THROUGH AI-DRIVEN LASER DIFFRACTION TECHNOLOGIES TO DRIVE MARKET
• 9.3 DYNAMIC LIGHT SCATTERING
  • 9.3.1 NEED FOR TRANSFORMING PARTICLE SIZE ANALYSIS THROUGH NEXT-GENERATION AI-DRIVEN DYNAMIC LIGHT SCATTERING (DLS) TECHNOLOGIES TO DRIVE MARKET
• 9.4 IMAGING
  • 9.4.1 GROWTH OF IMAGING-BASED PARTICLE SIZE ANALYSIS THROUGH AUTOMATION AND AI INTEGRATION TO BOOST GROWTH
    • 9.4.1.1 Dynamic imaging
    • 9.4.1.2 Static imaging
• 9.5 NANOPARTICLE TRACKING ANALYSIS (NTA)
  • 9.5.1 GROWTH OF NANOPARTICLE TRACKING ANALYSIS (NTA) IN ADVANCED SINGLE-PARTICLE CHARACTERIZATION AND BIOPHARMACEUTICAL APPLICATIONS TO BOOST GROWTH
• 9.6 COULTER PRINCIPLE
  • 9.6.1 FOCUS ON STRENGTHENING GROWTH OF COULTER PRINCIPLE-BASED PARTICLE SIZE ANALYSIS THROUGH HIGH-PRECISION ELECTRICAL SENSING TO BOOST DEMAND
• 9.7 SIEVE ANALYSIS
  • 9.7.1 DEVELOPMENT OF OTHER ADVANCED AND ACCURATE TECHNIQUES DISRUPTS GROWTH TO DRIVE MARKET
• 9.8 OTHER TECHNOLOGIES

10 PARTICLE SIZE ANALYSIS MARKET, BY END USER

• 10.1 INTRODUCTION
• 10.2 HEALTHCARE INDUSTRY
  • 10.2.1 ADVANCING PRECISION DIAGNOSTICS THROUGH HIGH-RESOLUTION PARTICLE CHARACTERIZATION
  • 10.2.2 PHARMA COS
    • 10.2.2.1 Increasing Regulatory Focus on Drug Quality and Growing Outsourcing of Particle Engineering Driving Adoption of Particle Size Analysis
    • 10.2.2.2 Process analytical technology
      • 10.2.2.2.1 Growing Adoption of Process Analytical Technology (PAT) and Continuous Manufacturing Accelerating Demand for Real-Time Particle Size Monitoring
    • 10.2.2.3 Other applications
      • 10.2.2.3.1 Expanding particle characterization across complex pharmaceutical manufacturing workflows
  • 10.2.3 BIOPHARMA COS
    • 10.2.3.1 Rapid Expansion of Biologics and Nanomedicines Driving Demand for Advanced Particle Characterization Technologies
    • 10.2.3.2 Process analytical technology
      • 10.2.3.2.1 Increasing adoption of process analytical technology in biopharmaceutical manufacturing driving real-time particle characterization
    • 10.2.3.3 Other applications
      • 10.2.3.3.1 Enhancing biologics development through advanced nanoparticle characterization
  • 10.2.4 PUBLIC & PRIVATE RESEARCH INSTITUTIONS
    • 10.2.4.1 Emphasis on strengthening drug development pipelines with AI-enabled particle size characterization technologies to drive market
  • 10.2.5 ACADEMIC INSTITUTIONS
    • 10.2.5.1 Need for strengthening university research capabilities with advanced particle size characterization technologies to drive market
• 10.3 COSMETIC INDUSTRY
  • 10.3.1 RAPID USE OF PRECISION PARTICLE SIZE CONTROL AND NANO-FORMULATION TECHNOLOGIES TO BOOST MARKET
• 10.4 CHEMICAL & PETROLEUM INDUSTRY
  • 10.4.1 NEED FOR MAINTAINING REFINERY AND PETROCHEMICAL EFFICIENCY VIA PRECISION PARTICLE SIZE ENGINEERING AND PROCESS OPTIMIZATION TO DRIVE MARKET
• 10.5 MINING, MINERALS, AND CEMENT INDUSTRY
  • 10.5.1 NEED TO ACCELERATE SUSTAINABLE MINING AND CEMENT PRODUCTION THROUGH DIGITAL PARTICLE SIZE MONITORING AND SMART GRINDING SYSTEMS TO BOOST GROWTH
• 10.6 FOOD & BEVERAGE INDUSTRY
  • 10.6.1 GROWING CONCERN OVER FOOD QUALITY & SAFETY COMPLIANCE, ESPECIALLY IN EMERGING COUNTRIES, TO DRIVE MARKET
• 10.7 OTHER INDUSTRIES

11 PARTICLE SIZE ANALYSIS MARKET, BY TYPE

• 11.1 INTRODUCTION
• 11.2 BENCHTOP ANALYZERS
  • 11.2.1 WIDE-SCALE USE FOR ENHANCED PRECISION AND EFFICIENCY IN MODERN LABORATORIES TO DRIVE MARKET
• 11.3 PORTABLE ANALYZERS
  • 11.3.1 REVOLUTIONIZING LANDSCAPE OF PARTICLE SIZE ANALYSIS TO BOOST GROWTH

12 PARTICLE SIZE ANALYSIS MARKET, BY REGION

• 12.1 INTRODUCTION
• 12.2 NORTH AMERICA
  • 12.2.1 US
    • 12.2.1.1 Presence of large pharmaceutical and biotechnological companies to support market growth
  • 12.2.2 CANADA
    • 12.2.2.1 Increasing number of conferences on nanotechnology to drive growth
• 12.3 EUROPE
  • 12.3.1 GERMANY
    • 12.3.1.1 Increasing number of conferences and workshops to push adoption of particle size analyzers
  • 12.3.2 UK
    • 12.3.2.1 Academia and research institutions to play major role in increased demand for particle size analyzers
  • 12.3.3 FRANCE
    • 12.3.3.1 Public-private investments in biotechnology and pharmaceutical R&D to support adoption of particle size analyzers
  • 12.3.4 ITALY
    • 12.3.4.1 Strong pharmaceutical manufacturing and R&D activities to support adoption of particle size analyzers
  • 12.3.5 SPAIN
    • 12.3.5.1 Favorable environment for pharma and biotech companies and SMEs to support demand
  • 12.3.6 REST OF EUROPE
• 12.4 ASIA PACIFIC
  • 12.4.1 CHINA
    • 12.4.1.1 Expanding pharmaceutical, nanotechnology, and research activities to drive demand for particle size analysis
  • 12.4.2 JAPAN
    • 12.4.2.1 Rising R&D expenditure to drive market
  • 12.4.3 INDIA
    • 12.4.3.1 Expanding pharmaceutical manufacturing and export capabilities to drive demand for particle size analysis
  • 12.4.4 AUSTRALIA
    • 12.4.4.1 Strong focus on pharmaceutical particle characterization and industrial particle analysis to support market growth
  • 12.4.5 SOUTH KOREA
    • 12.4.5.1 Strong government R&D investments and biotechnology innovation to drive market growth
  • 12.4.6 REST OF ASIA PACIFIC
• 12.5 LATIN AMERICA
  • 12.5.1 BRAZIL
    • 12.5.1.1 Expanding healthcare infrastructure and pharmaceutical activities to support demand for particle size analysis
  • 12.5.2 MEXICO
    • 12.5.2.1 Expanding mining, petroleum, and pharmaceutical industries to support demand for particle size analysis
  • 12.5.3 REST OF LATIN AMERICA
• 12.6 MIDDLE EAST & AFRICA
  • 12.6.1 MULTIPLE CONFERENCES AND EXHIBITIONS TO PROMOTE UTILIZATION OF PARTICLE SIZE ANALYZERS
  • 12.6.2 GCC COUNTRIES
    • 12.6.2.1 Accelerating pharmaceutical quality infrastructure through advanced particle characterization
  • 12.6.3 REST OF MIDDLE EAST & AFRICA

13 COMPETITIVE LANDSCAPE

• 13.1 OVERVIEW
• 13.2 KEY PLAYER STRATEGIES
  • 13.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN PARTICLE SIZE ANALYSIS MARKET
• 13.3 REVENUE SHARE ANALYSIS
• 13.4 MARKET SHARE ANALYSIS
  • 13.4.1 PARTICLE SIZE ANALYSIS MARKET SHARE, BY KEY PLAYER, 2025
• 13.5 COMPANY VALUATION & FINANCIAL METRICS
  • 13.5.1 FINANCIAL METRICS
  • 13.5.2 COMPANY VALUATION
• 13.6 BRAND/PRODUCT COMPARISON
• 13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS
  • 13.7.1 STARS
  • 13.7.2 EMERGING LEADERS
  • 13.7.3 PERVASIVE PLAYERS
  • 13.7.4 PARTICIPANTS
• 13.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  • 13.8.1 PROGRESSIVE COMPANIES
  • 13.8.2 RESPONSIVE COMPANIES
  • 13.8.3 DYNAMIC COMPANIES
  • 13.8.4 STARTING BLOCKS
  • 13.8.5 COMPETITIVE FOOTPRINT: KEY PLAYERS, 2025
    • 13.8.5.1 Company footprint
    • 13.8.5.2 Regional footprint
    • 13.8.5.3 Technology footprint
    • 13.8.5.4 Dispersion footprint
    • 13.8.5.5 Type footprint
    • 13.8.5.6 End user footprint
• 13.9 COMPANY EVALUATION MATRIX: STARTUPS/SMES
  • 13.9.1 PROGRESSIVE COMPANIES
  • 13.9.2 RESPONSIVE COMPANIES
  • 13.9.3 DYNAMIC COMPANIES
  • 13.9.4 STARTING BLOCKS
  • 13.9.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2025
• 13.10 COMPETITIVE SCENARIO
  • 13.10.1 PRODUCT LAUNCHES & APPROVALS
  • 13.10.2 DEALS
  • 13.10.3 EXPANSIONS

14 COMPANY PROFILES

• 14.1 KEY PLAYERS
  • 14.1.1 SPECTRIS
    • 14.1.1.1 Business overview
    • 14.1.1.2 Products offered
    • 14.1.1.3 Recent developments
      • 14.1.1.3.1 Deals
    • 14.1.1.4 MnM view
      • 14.1.1.4.1 Key strengths
      • 14.1.1.4.2 Strategic choices
      • 14.1.1.4.3 Weaknesses and competitive threats
  • 14.1.2 HORIBA
    • 14.1.2.1 Business overview
    • 14.1.2.2 Products offered
    • 14.1.2.3 Recent developments
      • 14.1.2.3.1 Product launches & approvals
    • 14.1.2.4 Expansions
    • 14.1.2.5 MnM view
      • 14.1.2.5.1 Key strengths
      • 14.1.2.5.2 Strategic choices
      • 14.1.2.5.3 Weaknesses and competitive threats
  • 14.1.3 DANAHER CORPORATION
    • 14.1.3.1 Business overview
    • 14.1.3.2 Products offered
    • 14.1.3.3 MnM view
      • 14.1.3.3.1 Key strengths
      • 14.1.3.3.2 Strategic choices
      • 14.1.3.3.3 Weaknesses and competitive threats
  • 14.1.4 ANTON PAAR GMBH
    • 14.1.4.1 Business overview
    • 14.1.4.2 Products offered
    • 14.1.4.3 Recent developments
      • 14.1.4.3.1 Product launches & approvals
      • 14.1.4.3.2 Deals
      • 14.1.4.3.3 Expansions
    • 14.1.4.4 MnM view
      • 14.1.4.4.1 Key Strengths
      • 14.1.4.4.2 Strategic Choices
      • 14.1.4.4.3 Weaknesses and Competitive Threats
  • 14.1.5 BETTERSIZE INSTRUMENTS LTD.
    • 14.1.5.1 Business overview
    • 14.1.5.2 Products offered
    • 14.1.5.3 Recent developments
      • 14.1.5.3.1 Product launches & approvals
      • 14.1.5.3.2 Deals
      • 14.1.5.3.3 Expansions
    • 14.1.5.4 MnM view
      • 14.1.5.4.1 Key strengths
      • 14.1.5.4.2 Strategic choices
      • 14.1.5.4.3 Weaknesses and competitive threats
  • 14.1.6 NOVA VENTURES GROUP
    • 14.1.6.1 Business overview
    • 14.1.6.2 Products offered
  • 14.1.7 FRITSCH GMBH
    • 14.1.7.1 Business overview
    • 14.1.7.2 Products offered
    • 14.1.7.3 Recent developments
      • 14.1.7.3.1 Product launches & approvals
  • 14.1.8 LS INSTRUMENTS
    • 14.1.8.1 Business overview
    • 14.1.8.2 Products offered
    • 14.1.8.3 Recent developments
      • 14.1.8.3.1 Deals
      • 14.1.8.3.2 Expansions
  • 14.1.9 METTLER TOLEDO
    • 14.1.9.1 Business overview
    • 14.1.9.2 Products offered
  • 14.1.10 VERDER SCIENTIFIC GMBH & CO. KG
    • 14.1.10.1 Business overview
    • 14.1.10.2 Products offered
    • 14.1.10.3 Recent developments
      • 14.1.10.3.1 Deals
      • 14.1.10.3.2 Expansions
  • 14.1.11 SYMPATEC GMBH
    • 14.1.11.1 Business overview
    • 14.1.11.2 Products offered
    • 14.1.11.3 Recent developments
      • 14.1.11.3.1 Expansions
  • 14.1.12 SHIMADZU CORPORATION
    • 14.1.12.1 Business overview
    • 14.1.12.2 Products offered
    • 14.1.12.3 Recent developments
      • 14.1.12.3.1 Expansions
  • 14.1.13 TSI
    • 14.1.13.1 Business overview
    • 14.1.13.2 Products offered
  • 14.1.14 DANDONG HMKTEST INSTRUMENT CO., LTD.
    • 14.1.14.1 Business overview
    • 14.1.14.2 Products offered
  • 14.1.15 MICROMERITICS INSTRUMENT CORPORATION
    • 14.1.15.1 Business overview
    • 14.1.15.2 Products offered
    • 14.1.15.3 Recent developments
      • 14.1.15.3.1 Deals
• 14.2 OTHER PLAYERS
  • 14.2.1 PAMAS PARTIKELMESS - UND ANALYSESYTEME GMBH
  • 14.2.2 JINAN WINNER PARTICLE INSTRUMENT STOCK CO., LTD.
  • 14.2.3 3P INSTRUMENTS
  • 14.2.4 IZON SCIENCE LIMITED
  • 14.2.5 CSC SCIENTIFIC COMPANY, INC.
  • 14.2.6 INPROCESS-LSP
  • 14.2.7 YOKOGAWA FLUID IMAGING TECHNOLOGIES, INC
  • 14.2.8 APIX ANALYTICS
  • 14.2.9 GENIZER LLC
  • 14.2.10 TECHNOVALUE

15 RESEARCH METHODOLOGY

• 15.1 RESEARCH DATA
  • 15.1.1 SECONDARY DATA
    • 15.1.1.1 Key data from secondary sources
    • 15.1.1.2 Objectives of secondary research
  • 15.1.2 PRIMARY DATA
    • 15.1.2.1 Objectives of primary research
    • 15.1.2.2 Key industry insights
• 15.2 MARKET SIZE ESTIMATION
  • 15.2.1 BOTTOM-UP APPROACH
    • 15.2.1.1 Approach 1: Company revenue estimation approach
    • 15.2.1.2 Approach 4: Primary interviews
  • 15.2.2 TOP-DOWN APPROACH
• 15.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 15.4 MARKET SHARE ASSESSMENT
• 15.5 RESEARCH ASSUMPTIONS
• 15.6 RESEARCH LIMITATIONS
• 15.7 RISK ASSESSMENT

16 APPENDIX

• 16.1 DISCUSSION GUIDE
• 16.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 16.3 CUSTOMIZATION OPTIONS
• 16.4 RELATED REPORTS
• 16.5 AUTHOR DETAILS